More needs to be spent on hepatitis C treatment, not less

Intern Med J. 2018 Mar;48(3):364-366. doi: 10.1111/imj.13718.

Authors

Paul J Clark^{1

2

3}, Chiho Muranushi⁴, Samantha A Hollingworth⁴

Affiliations

¹ Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
² Princess Alexandra and Mater Hospitals, Brisbane, Queensland, Australia.
³ Cancer and Chronic Disease Research Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
⁴ School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia.

PMID: 29512321
DOI: 10.1111/imj.13718

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Australia / epidemiology
Health Expenditures / trends*
Hepatitis C / economics*
Hepatitis C / epidemiology
Hepatitis C / therapy*
Humans
Treatment Outcome